Matinas BioPharma Holdings, Inc. (MTNB)
0.1842
0.00 (0.00%)
USD |
NYAM |
Sep 09, 10:55
Matinas BioPharma Holdings EPS Diluted (Quarterly) : -0.207 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.207 |
| March 31, 2026 | -0.2999 |
| December 31, 2025 | -0.2985 |
| September 30, 2025 | -0.3955 |
| June 30, 2025 | -1.031 |
| March 31, 2025 | -0.3255 |
| December 31, 2024 | -1.658 |
| September 30, 2024 | -0.8486 |
| June 30, 2024 | -1.147 |
| March 31, 2024 | -1.340 |
| December 31, 2023 | -1.223 |
| September 30, 2023 | -1.394 |
| June 30, 2023 | -1.394 |
| March 31, 2023 | -1.268 |
| December 31, 2022 | -0.838 |
| September 30, 2022 | -1.259 |
| June 30, 2022 | -1.366 |
| March 31, 2022 | -1.380 |
| December 31, 2021 | -1.549 |
| September 30, 2021 | -1.588 |
| June 30, 2021 | -1.212 |
| March 31, 2021 | -1.268 |
| December 31, 2020 | -1.645 |
| September 30, 2020 | -1.427 |
| June 30, 2020 | -1.464 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.361 |
| December 31, 2019 | -1.784 |
| September 30, 2019 | -1.455 |
| June 30, 2019 | -1.260 |
| March 31, 2019 | -1.838 |
| December 31, 2018 | -1.744 |
| September 30, 2018 | -1.72 |
| June 30, 2018 | -2.00 |
| March 31, 2018 | -2.276 |
| December 31, 2017 | -1.943 |
| September 30, 2017 | -1.922 |
| June 30, 2017 | -2.00 |
| March 31, 2017 | -12.50 |
| December 31, 2016 | -1.50 |
| September 30, 2016 | -5.50 |
| June 30, 2016 | -1.50 |
| March 31, 2016 | -2.00 |
| December 31, 2015 | -2.00 |
| September 30, 2015 | -2.00 |
| June 30, 2015 | -2.00 |
| March 31, 2015 | -3.50 |
| December 31, 2014 | -4.714 |
| September 30, 2014 | -4.00 |
| June 30, 2014 | -4.00 |
| March 31, 2014 | -3.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.326M |
| Total Expenses (Quarterly) | 1.326M |
| Enterprise Value | 0.3609M |
| Earnings Yield | -652.0% |
| Normalized Earnings Yield | -673.72 |